Nimodipine vs. Milrinone – Equal or Complementary Use? A Retrospective Analysis

BACKGROUND: Cerebral vasospasm (CVS) continues to account for high morbidity and mortality in patients surviving the initial aneurysmal subarachnoid hemorrhage (SAH). Nimodipine is the only drug known to reduce delayed cerebral ischemia (DCI), but it is believed not to affect large vessel CVS. Milri...

Descripción completa

Detalles Bibliográficos
Autores principales: Jentzsch, Jennifer, Ziganshyna, Svitlana, Lindner, Dirk, Merkel, Helena, Mucha, Simone, Schob, Stefan, Quäschling, Ulf, Hoffmann, Karl-Titus, Werdehausen, Robert, Halama, Dirk, Gaber, Khaled, Richter, Cindy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330364/
https://www.ncbi.nlm.nih.gov/pubmed/35911878
http://dx.doi.org/10.3389/fneur.2022.939015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330364/
https://www.ncbi.nlm.nih.gov/pubmed/35911878
http://dx.doi.org/10.3389/fneur.2022.939015

Ejemplares similares